![]() |
Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
More... |
| All times are GMT -7. The time now is 05:07 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021